Document Detail


The structure of ribosome-lankacidin complex reveals ribosomal sites for synergistic antibiotics.
MedLine Citation:
PMID:  20080686     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Crystallographic analysis revealed that the 17-member polyketide antibiotic lankacidin produced by Streptomyces rochei binds at the peptidyl transferase center of the eubacterial large ribosomal subunit. Biochemical and functional studies verified this finding and showed interference with peptide bond formation. Chemical probing indicated that the macrolide lankamycin, a second antibiotic produced by the same species, binds at a neighboring site, at the ribosome exit tunnel. These two antibiotics can bind to the ribosome simultaneously and display synergy in inhibiting bacterial growth. The binding site of lankacidin and lankamycin partially overlap with the binding site of another pair of synergistic antibiotics, the streptogramins. Thus, at least two pairs of structurally dissimilar compounds have been selected in the course of evolution to act synergistically by targeting neighboring sites in the ribosome. These results underscore the importance of the corresponding ribosomal sites for development of clinically relevant synergistic antibiotics and demonstrate the utility of structural analysis for providing new directions for drug discovery.
Authors:
Tamar Auerbach; Inbal Mermershtain; Chen Davidovich; Anat Bashan; Matthew Belousoff; Itai Wekselman; Ella Zimmerman; Liqun Xiong; Dorota Klepacki; Kenji Arakawa; Haruyasu Kinashi; Alexander S Mankin; Ada Yonath
Related Documents :
9478206 - Ribosomal binding of modified trna anticodons related to thermal stability.
1831176 - Assembly of transcription elongation complexes containing the n protein of phage lambda...
17027976 - Mapping contacts of the s12-s7 intercistronic region of str operon mrna with ribosomal ...
12509466 - Eukaryotic initiation factors 4g and 4a mediate conformational changes downstream of th...
8303096 - Melatonin receptors in purified cell nuclei of liver.
9457616 - The cannabinoid receptor: computer-aided molecular modeling and docking of ligand.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-01-11
Journal Detail:
Title:  Proceedings of the National Academy of Sciences of the United States of America     Volume:  107     ISSN:  1091-6490     ISO Abbreviation:  Proc. Natl. Acad. Sci. U.S.A.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-05     Completed Date:  2010-03-05     Revised Date:  2010-09-27    
Medline Journal Info:
Nlm Unique ID:  7505876     Medline TA:  Proc Natl Acad Sci U S A     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1983-8     Citation Subset:  IM    
Affiliation:
Department of Structural Biology, Weizmann Institute of Science, Rehovot 76100, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Bacterial Agents / chemistry*,  metabolism*
Binding Sites
Crystallography, X-Ray
Deinococcus / chemistry,  metabolism
Drug Discovery
Drug Synergism
Erythromycin / analogs & derivatives,  chemistry,  metabolism
Macrolides / chemistry*,  metabolism*
Models, Molecular
Molecular Structure
Ribosome Subunits, Large, Bacterial / chemistry,  metabolism
Ribosomes / chemistry*,  metabolism*
Grant Support
ID/Acronym/Agency:
GM34360/GM/NIGMS NIH HHS; U19 AI56575/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Macrolides; 114-07-8/Erythromycin; 23623-31-6/lankacidins; 30042-37-6/kujimycin B
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activ...
Next Document:  Cocaine is pharmacologically active in the nonhuman primate fetal brain.